-

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080224650

Enrollment

320

Registered

2019-04-18

Start date

2019-05-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : - INN of investigational material : relugolix Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosage and

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: -

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
efficacy confirmatory -	—

Secondary

Measure	Time frame
efficacy -	—

Countries

Japan

Outcome results